The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-N-(1-cyanocyclopropyl)-3-(methylsulfinyl)-2-((S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethylamino)propanamide ID: ALA250119
PubChem CID: 23648281
Max Phase: Preclinical
Molecular Formula: C16H17F4N3O2S
Molecular Weight: 391.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C[S+]([O-])C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1
Standard InChI: InChI=1S/C16H17F4N3O2S/c1-26(25)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24)/t12-,13-,26?/m0/s1
Standard InChI Key: RTEXRRVBLWMVBG-GXXHEZNASA-N
Molfile:
RDKit 2D
26 27 0 0 1 0 0 0 0 0999 V2000
5.4071 -0.1290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1247 -0.9073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9407 -0.7598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0141 -5.8755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7339 -5.4645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7362 -4.6307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0148 -4.2152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2940 -4.6307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2948 -5.4619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5745 -4.2226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5691 -3.3900 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8512 -2.9805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8442 -2.1497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1259 -1.7375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5655 -1.7276 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3101 -0.7644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4935 -0.6231 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1366 -3.3987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8601 -4.6407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1441 -5.0596 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.4386 -3.9204 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.2765 -5.3523 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.4152 -2.9851 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.6981 -3.4022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4126 -2.1557 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4508 -5.8818 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 3 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
14 2 1 0
2 16 1 0
16 17 3 0
12 18 1 1
10 19 1 1
19 20 1 0
19 21 1 0
19 22 1 0
18 23 1 0
23 24 1 0
2 1 1 0
23 25 1 0
3 2 1 0
5 26 1 0
M CHG 2 23 1 25 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 391.39Molecular Weight (Monoisotopic): 391.0978AlogP: 1.94#Rotatable Bonds: 7Polar Surface Area: 87.98Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.50CX Basic pKa: 2.40CX LogP: 0.60CX LogD: 0.60Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.55Np Likeness Score: -1.03
References 1. Gauthier JY, Black WC, Courchesne I, Cromlish W, Desmarais S, Houle R, Lamontagne S, Li CS, Massé F, McKay DJ, Ouellet M, Robichaud J, Truchon JF, Truong VL, Wang Q, Percival MD.. (2007) The identification of potent, selective, and bioavailable cathepsin S inhibitors., 17 (17): [PMID:17590332 ] [10.1016/j.bmcl.2007.06.023 ]